Electrophoresis Comprehensive Study by Type (Electrophoresis Reagents, Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Gel Documentation Systems, Software), Application (Diagnostic, Research, Quality Control, Process Validation), End Users (Academic Institutions, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Research Organizations) Players and Region - Global Market Outlook to 2030

Electrophoresis Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.5%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Electrophoresis
Electrophoresis is a process that separates the charged particles by using an electrical charge in a fluid. It is used for the separation of protein molecules or DNA in life sciences. It can be achieved using different procedures and also depends on the type of molecules. It uses different reagents for separation of molecules such as dyes, gels, and buffers. The electrophoresis is widely used in medical diagnostics, life sciences and clinical research. These applications are creating a demand of electrophoresis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR5.5%


The future of the electrophoresis market is bright, with continued advancements in technology and new applications emerging across various fields. As competition intensifies, players will need to adapt and innovate to stay ahead of the curve, ensuring the electrophoresis market remains a charged and dynamic space for scientific discovery and innovation. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bio-Rad Laboratories (United States), GE Healthcare (United States), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Agilent Technologies (United States), Merck Millipore (United States), PerkinElmer, Inc. (United States) and QIAGEN N.V. (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Harvard Bioscience, Inc. (United Sates), C.B.S. Scientific Company, Inc. (United States), Lonza Group Ltd. (Switzerland) and Shimadzu Corporation (Japan).

Segmentation Overview
AMA Research has segmented the market of Global Electrophoresis market by Type (Electrophoresis Reagents, Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Gel Documentation Systems and Software), Application (Diagnostic, Research, Quality Control and Process Validation) and Region.



On the basis of geography, the market of Electrophoresis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End Users, the sub-segment i.e. Academic Institutions will boost the Electrophoresis market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Rising Adoption of Capillary Electrophoresis among the Chemical Industries

Market Growth Drivers:
Raising Prevalence of Diseases Such as Cancer, Infectious Diseases, and Genetic Disorders and Growing Need of Separation of Cancer Proteins in Various Research and Development Organisations.

Challenges:
Availability of Alternative Technology may hamper the Market Growth

Restraints:
Increasing Number of Research Laboratories

Opportunities:
Increasing Investments in Research and Developments and Rising Integration and Collaboration among Various Industries

Market Leaders and their expansionary development strategies
In December 2023, Thermo Fisher Scientific collaborates with a leading research institute to develop microfluidic electrophoresis chips for point-of-care diagnostics applications, aiming to bring rapid and decentralized testing closer to patients. and Trends Shaping the Market.
In November 2023, Qiagen unveils the QIAxcel Connect system, integrating its automated gel electrophoresis technology with a cloud-based data management platform for streamlined sample analysis and collaboration.


Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Electrophoresis Reagents
  • Gel Electrophoresis Systems
  • Capillary Electrophoresis Systems
  • Gel Documentation Systems
  • Software
By Application
  • Diagnostic
  • Research
  • Quality Control
  • Process Validation
By End Users
  • Academic Institutions
  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Research Organizations

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Raising Prevalence of Diseases Such as Cancer, Infectious Diseases, and Genetic Disorders
      • 3.2.2. Growing Need of Separation of Cancer Proteins in Various Research and Development Organisations.
    • 3.3. Market Challenges
      • 3.3.1. Availability of Alternative Technology may hamper the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Rising Adoption of Capillary Electrophoresis among the Chemical Industries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Electrophoresis, by Type, Application, End Users and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Electrophoresis (Value)
      • 5.2.1. Global Electrophoresis by: Type (Value)
        • 5.2.1.1. Electrophoresis Reagents
        • 5.2.1.2. Gel Electrophoresis Systems
        • 5.2.1.3. Capillary Electrophoresis Systems
        • 5.2.1.4. Gel Documentation Systems
        • 5.2.1.5. Software
      • 5.2.2. Global Electrophoresis by: Application (Value)
        • 5.2.2.1. Diagnostic
        • 5.2.2.2. Research
        • 5.2.2.3. Quality Control
        • 5.2.2.4. Process Validation
      • 5.2.3. Global Electrophoresis by: End Users (Value)
        • 5.2.3.1. Academic Institutions
        • 5.2.3.2. Hospitals & Diagnostic Centers
        • 5.2.3.3. Pharmaceutical & Biotechnology Companies
        • 5.2.3.4. Research Organizations
      • 5.2.4. Global Electrophoresis Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Electrophoresis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GE Healthcare (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher Scientific Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Danaher Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Agilent Technologies (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merck Millipore (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PerkinElmer, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. QIAGEN N.V. (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Electrophoresis Sale, by Type, Application, End Users and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Electrophoresis (Value)
      • 7.2.1. Global Electrophoresis by: Type (Value)
        • 7.2.1.1. Electrophoresis Reagents
        • 7.2.1.2. Gel Electrophoresis Systems
        • 7.2.1.3. Capillary Electrophoresis Systems
        • 7.2.1.4. Gel Documentation Systems
        • 7.2.1.5. Software
      • 7.2.2. Global Electrophoresis by: Application (Value)
        • 7.2.2.1. Diagnostic
        • 7.2.2.2. Research
        • 7.2.2.3. Quality Control
        • 7.2.2.4. Process Validation
      • 7.2.3. Global Electrophoresis by: End Users (Value)
        • 7.2.3.1. Academic Institutions
        • 7.2.3.2. Hospitals & Diagnostic Centers
        • 7.2.3.3. Pharmaceutical & Biotechnology Companies
        • 7.2.3.4. Research Organizations
      • 7.2.4. Global Electrophoresis Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Electrophoresis: by Type(USD Million)
  • Table 2. Electrophoresis Electrophoresis Reagents , by Region USD Million (2018-2023)
  • Table 3. Electrophoresis Gel Electrophoresis Systems , by Region USD Million (2018-2023)
  • Table 4. Electrophoresis Capillary Electrophoresis Systems , by Region USD Million (2018-2023)
  • Table 5. Electrophoresis Gel Documentation Systems , by Region USD Million (2018-2023)
  • Table 6. Electrophoresis Software , by Region USD Million (2018-2023)
  • Table 7. Electrophoresis: by Application(USD Million)
  • Table 8. Electrophoresis Diagnostic , by Region USD Million (2018-2023)
  • Table 9. Electrophoresis Research , by Region USD Million (2018-2023)
  • Table 10. Electrophoresis Quality Control , by Region USD Million (2018-2023)
  • Table 11. Electrophoresis Process Validation , by Region USD Million (2018-2023)
  • Table 12. Electrophoresis: by End Users(USD Million)
  • Table 13. Electrophoresis Academic Institutions , by Region USD Million (2018-2023)
  • Table 14. Electrophoresis Hospitals & Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 15. Electrophoresis Pharmaceutical & Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 16. Electrophoresis Research Organizations , by Region USD Million (2018-2023)
  • Table 17. South America Electrophoresis, by Country USD Million (2018-2023)
  • Table 18. South America Electrophoresis, by Type USD Million (2018-2023)
  • Table 19. South America Electrophoresis, by Application USD Million (2018-2023)
  • Table 20. South America Electrophoresis, by End Users USD Million (2018-2023)
  • Table 21. Brazil Electrophoresis, by Type USD Million (2018-2023)
  • Table 22. Brazil Electrophoresis, by Application USD Million (2018-2023)
  • Table 23. Brazil Electrophoresis, by End Users USD Million (2018-2023)
  • Table 24. Argentina Electrophoresis, by Type USD Million (2018-2023)
  • Table 25. Argentina Electrophoresis, by Application USD Million (2018-2023)
  • Table 26. Argentina Electrophoresis, by End Users USD Million (2018-2023)
  • Table 27. Rest of South America Electrophoresis, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Electrophoresis, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Electrophoresis, by End Users USD Million (2018-2023)
  • Table 30. Asia Pacific Electrophoresis, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Electrophoresis, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Electrophoresis, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific Electrophoresis, by End Users USD Million (2018-2023)
  • Table 34. China Electrophoresis, by Type USD Million (2018-2023)
  • Table 35. China Electrophoresis, by Application USD Million (2018-2023)
  • Table 36. China Electrophoresis, by End Users USD Million (2018-2023)
  • Table 37. Japan Electrophoresis, by Type USD Million (2018-2023)
  • Table 38. Japan Electrophoresis, by Application USD Million (2018-2023)
  • Table 39. Japan Electrophoresis, by End Users USD Million (2018-2023)
  • Table 40. India Electrophoresis, by Type USD Million (2018-2023)
  • Table 41. India Electrophoresis, by Application USD Million (2018-2023)
  • Table 42. India Electrophoresis, by End Users USD Million (2018-2023)
  • Table 43. South Korea Electrophoresis, by Type USD Million (2018-2023)
  • Table 44. South Korea Electrophoresis, by Application USD Million (2018-2023)
  • Table 45. South Korea Electrophoresis, by End Users USD Million (2018-2023)
  • Table 46. Taiwan Electrophoresis, by Type USD Million (2018-2023)
  • Table 47. Taiwan Electrophoresis, by Application USD Million (2018-2023)
  • Table 48. Taiwan Electrophoresis, by End Users USD Million (2018-2023)
  • Table 49. Australia Electrophoresis, by Type USD Million (2018-2023)
  • Table 50. Australia Electrophoresis, by Application USD Million (2018-2023)
  • Table 51. Australia Electrophoresis, by End Users USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Electrophoresis, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Electrophoresis, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Electrophoresis, by End Users USD Million (2018-2023)
  • Table 55. Europe Electrophoresis, by Country USD Million (2018-2023)
  • Table 56. Europe Electrophoresis, by Type USD Million (2018-2023)
  • Table 57. Europe Electrophoresis, by Application USD Million (2018-2023)
  • Table 58. Europe Electrophoresis, by End Users USD Million (2018-2023)
  • Table 59. Germany Electrophoresis, by Type USD Million (2018-2023)
  • Table 60. Germany Electrophoresis, by Application USD Million (2018-2023)
  • Table 61. Germany Electrophoresis, by End Users USD Million (2018-2023)
  • Table 62. France Electrophoresis, by Type USD Million (2018-2023)
  • Table 63. France Electrophoresis, by Application USD Million (2018-2023)
  • Table 64. France Electrophoresis, by End Users USD Million (2018-2023)
  • Table 65. Italy Electrophoresis, by Type USD Million (2018-2023)
  • Table 66. Italy Electrophoresis, by Application USD Million (2018-2023)
  • Table 67. Italy Electrophoresis, by End Users USD Million (2018-2023)
  • Table 68. United Kingdom Electrophoresis, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Electrophoresis, by Application USD Million (2018-2023)
  • Table 70. United Kingdom Electrophoresis, by End Users USD Million (2018-2023)
  • Table 71. Netherlands Electrophoresis, by Type USD Million (2018-2023)
  • Table 72. Netherlands Electrophoresis, by Application USD Million (2018-2023)
  • Table 73. Netherlands Electrophoresis, by End Users USD Million (2018-2023)
  • Table 74. Rest of Europe Electrophoresis, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Electrophoresis, by Application USD Million (2018-2023)
  • Table 76. Rest of Europe Electrophoresis, by End Users USD Million (2018-2023)
  • Table 77. MEA Electrophoresis, by Country USD Million (2018-2023)
  • Table 78. MEA Electrophoresis, by Type USD Million (2018-2023)
  • Table 79. MEA Electrophoresis, by Application USD Million (2018-2023)
  • Table 80. MEA Electrophoresis, by End Users USD Million (2018-2023)
  • Table 81. Middle East Electrophoresis, by Type USD Million (2018-2023)
  • Table 82. Middle East Electrophoresis, by Application USD Million (2018-2023)
  • Table 83. Middle East Electrophoresis, by End Users USD Million (2018-2023)
  • Table 84. Africa Electrophoresis, by Type USD Million (2018-2023)
  • Table 85. Africa Electrophoresis, by Application USD Million (2018-2023)
  • Table 86. Africa Electrophoresis, by End Users USD Million (2018-2023)
  • Table 87. North America Electrophoresis, by Country USD Million (2018-2023)
  • Table 88. North America Electrophoresis, by Type USD Million (2018-2023)
  • Table 89. North America Electrophoresis, by Application USD Million (2018-2023)
  • Table 90. North America Electrophoresis, by End Users USD Million (2018-2023)
  • Table 91. United States Electrophoresis, by Type USD Million (2018-2023)
  • Table 92. United States Electrophoresis, by Application USD Million (2018-2023)
  • Table 93. United States Electrophoresis, by End Users USD Million (2018-2023)
  • Table 94. Canada Electrophoresis, by Type USD Million (2018-2023)
  • Table 95. Canada Electrophoresis, by Application USD Million (2018-2023)
  • Table 96. Canada Electrophoresis, by End Users USD Million (2018-2023)
  • Table 97. Mexico Electrophoresis, by Type USD Million (2018-2023)
  • Table 98. Mexico Electrophoresis, by Application USD Million (2018-2023)
  • Table 99. Mexico Electrophoresis, by End Users USD Million (2018-2023)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Electrophoresis: by Type(USD Million)
  • Table 109. Electrophoresis Electrophoresis Reagents , by Region USD Million (2025-2030)
  • Table 110. Electrophoresis Gel Electrophoresis Systems , by Region USD Million (2025-2030)
  • Table 111. Electrophoresis Capillary Electrophoresis Systems , by Region USD Million (2025-2030)
  • Table 112. Electrophoresis Gel Documentation Systems , by Region USD Million (2025-2030)
  • Table 113. Electrophoresis Software , by Region USD Million (2025-2030)
  • Table 114. Electrophoresis: by Application(USD Million)
  • Table 115. Electrophoresis Diagnostic , by Region USD Million (2025-2030)
  • Table 116. Electrophoresis Research , by Region USD Million (2025-2030)
  • Table 117. Electrophoresis Quality Control , by Region USD Million (2025-2030)
  • Table 118. Electrophoresis Process Validation , by Region USD Million (2025-2030)
  • Table 119. Electrophoresis: by End Users(USD Million)
  • Table 120. Electrophoresis Academic Institutions , by Region USD Million (2025-2030)
  • Table 121. Electrophoresis Hospitals & Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 122. Electrophoresis Pharmaceutical & Biotechnology Companies , by Region USD Million (2025-2030)
  • Table 123. Electrophoresis Research Organizations , by Region USD Million (2025-2030)
  • Table 124. South America Electrophoresis, by Country USD Million (2025-2030)
  • Table 125. South America Electrophoresis, by Type USD Million (2025-2030)
  • Table 126. South America Electrophoresis, by Application USD Million (2025-2030)
  • Table 127. South America Electrophoresis, by End Users USD Million (2025-2030)
  • Table 128. Brazil Electrophoresis, by Type USD Million (2025-2030)
  • Table 129. Brazil Electrophoresis, by Application USD Million (2025-2030)
  • Table 130. Brazil Electrophoresis, by End Users USD Million (2025-2030)
  • Table 131. Argentina Electrophoresis, by Type USD Million (2025-2030)
  • Table 132. Argentina Electrophoresis, by Application USD Million (2025-2030)
  • Table 133. Argentina Electrophoresis, by End Users USD Million (2025-2030)
  • Table 134. Rest of South America Electrophoresis, by Type USD Million (2025-2030)
  • Table 135. Rest of South America Electrophoresis, by Application USD Million (2025-2030)
  • Table 136. Rest of South America Electrophoresis, by End Users USD Million (2025-2030)
  • Table 137. Asia Pacific Electrophoresis, by Country USD Million (2025-2030)
  • Table 138. Asia Pacific Electrophoresis, by Type USD Million (2025-2030)
  • Table 139. Asia Pacific Electrophoresis, by Application USD Million (2025-2030)
  • Table 140. Asia Pacific Electrophoresis, by End Users USD Million (2025-2030)
  • Table 141. China Electrophoresis, by Type USD Million (2025-2030)
  • Table 142. China Electrophoresis, by Application USD Million (2025-2030)
  • Table 143. China Electrophoresis, by End Users USD Million (2025-2030)
  • Table 144. Japan Electrophoresis, by Type USD Million (2025-2030)
  • Table 145. Japan Electrophoresis, by Application USD Million (2025-2030)
  • Table 146. Japan Electrophoresis, by End Users USD Million (2025-2030)
  • Table 147. India Electrophoresis, by Type USD Million (2025-2030)
  • Table 148. India Electrophoresis, by Application USD Million (2025-2030)
  • Table 149. India Electrophoresis, by End Users USD Million (2025-2030)
  • Table 150. South Korea Electrophoresis, by Type USD Million (2025-2030)
  • Table 151. South Korea Electrophoresis, by Application USD Million (2025-2030)
  • Table 152. South Korea Electrophoresis, by End Users USD Million (2025-2030)
  • Table 153. Taiwan Electrophoresis, by Type USD Million (2025-2030)
  • Table 154. Taiwan Electrophoresis, by Application USD Million (2025-2030)
  • Table 155. Taiwan Electrophoresis, by End Users USD Million (2025-2030)
  • Table 156. Australia Electrophoresis, by Type USD Million (2025-2030)
  • Table 157. Australia Electrophoresis, by Application USD Million (2025-2030)
  • Table 158. Australia Electrophoresis, by End Users USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Electrophoresis, by Type USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Electrophoresis, by Application USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Electrophoresis, by End Users USD Million (2025-2030)
  • Table 162. Europe Electrophoresis, by Country USD Million (2025-2030)
  • Table 163. Europe Electrophoresis, by Type USD Million (2025-2030)
  • Table 164. Europe Electrophoresis, by Application USD Million (2025-2030)
  • Table 165. Europe Electrophoresis, by End Users USD Million (2025-2030)
  • Table 166. Germany Electrophoresis, by Type USD Million (2025-2030)
  • Table 167. Germany Electrophoresis, by Application USD Million (2025-2030)
  • Table 168. Germany Electrophoresis, by End Users USD Million (2025-2030)
  • Table 169. France Electrophoresis, by Type USD Million (2025-2030)
  • Table 170. France Electrophoresis, by Application USD Million (2025-2030)
  • Table 171. France Electrophoresis, by End Users USD Million (2025-2030)
  • Table 172. Italy Electrophoresis, by Type USD Million (2025-2030)
  • Table 173. Italy Electrophoresis, by Application USD Million (2025-2030)
  • Table 174. Italy Electrophoresis, by End Users USD Million (2025-2030)
  • Table 175. United Kingdom Electrophoresis, by Type USD Million (2025-2030)
  • Table 176. United Kingdom Electrophoresis, by Application USD Million (2025-2030)
  • Table 177. United Kingdom Electrophoresis, by End Users USD Million (2025-2030)
  • Table 178. Netherlands Electrophoresis, by Type USD Million (2025-2030)
  • Table 179. Netherlands Electrophoresis, by Application USD Million (2025-2030)
  • Table 180. Netherlands Electrophoresis, by End Users USD Million (2025-2030)
  • Table 181. Rest of Europe Electrophoresis, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe Electrophoresis, by Application USD Million (2025-2030)
  • Table 183. Rest of Europe Electrophoresis, by End Users USD Million (2025-2030)
  • Table 184. MEA Electrophoresis, by Country USD Million (2025-2030)
  • Table 185. MEA Electrophoresis, by Type USD Million (2025-2030)
  • Table 186. MEA Electrophoresis, by Application USD Million (2025-2030)
  • Table 187. MEA Electrophoresis, by End Users USD Million (2025-2030)
  • Table 188. Middle East Electrophoresis, by Type USD Million (2025-2030)
  • Table 189. Middle East Electrophoresis, by Application USD Million (2025-2030)
  • Table 190. Middle East Electrophoresis, by End Users USD Million (2025-2030)
  • Table 191. Africa Electrophoresis, by Type USD Million (2025-2030)
  • Table 192. Africa Electrophoresis, by Application USD Million (2025-2030)
  • Table 193. Africa Electrophoresis, by End Users USD Million (2025-2030)
  • Table 194. North America Electrophoresis, by Country USD Million (2025-2030)
  • Table 195. North America Electrophoresis, by Type USD Million (2025-2030)
  • Table 196. North America Electrophoresis, by Application USD Million (2025-2030)
  • Table 197. North America Electrophoresis, by End Users USD Million (2025-2030)
  • Table 198. United States Electrophoresis, by Type USD Million (2025-2030)
  • Table 199. United States Electrophoresis, by Application USD Million (2025-2030)
  • Table 200. United States Electrophoresis, by End Users USD Million (2025-2030)
  • Table 201. Canada Electrophoresis, by Type USD Million (2025-2030)
  • Table 202. Canada Electrophoresis, by Application USD Million (2025-2030)
  • Table 203. Canada Electrophoresis, by End Users USD Million (2025-2030)
  • Table 204. Mexico Electrophoresis, by Type USD Million (2025-2030)
  • Table 205. Mexico Electrophoresis, by Application USD Million (2025-2030)
  • Table 206. Mexico Electrophoresis, by End Users USD Million (2025-2030)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Electrophoresis: by Type USD Million (2018-2023)
  • Figure 5. Global Electrophoresis: by Application USD Million (2018-2023)
  • Figure 6. Global Electrophoresis: by End Users USD Million (2018-2023)
  • Figure 7. South America Electrophoresis Share (%), by Country
  • Figure 8. Asia Pacific Electrophoresis Share (%), by Country
  • Figure 9. Europe Electrophoresis Share (%), by Country
  • Figure 10. MEA Electrophoresis Share (%), by Country
  • Figure 11. North America Electrophoresis Share (%), by Country
  • Figure 12. Global Electrophoresis share by Players 2023 (%)
  • Figure 13. Global Electrophoresis share by Players (Top 3) 2023(%)
  • Figure 14. Global Electrophoresis share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 17. Bio-Rad Laboratories (United States) Revenue: by Geography 2023
  • Figure 18. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 19. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 20. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2023
  • Figure 22. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 23. Danaher Corporation (United States) Revenue: by Geography 2023
  • Figure 24. Agilent Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 25. Agilent Technologies (United States) Revenue: by Geography 2023
  • Figure 26. Merck Millipore (United States) Revenue, Net Income and Gross profit
  • Figure 27. Merck Millipore (United States) Revenue: by Geography 2023
  • Figure 28. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 29. PerkinElmer, Inc. (United States) Revenue: by Geography 2023
  • Figure 30. QIAGEN N.V. (Germany) Revenue, Net Income and Gross profit
  • Figure 31. QIAGEN N.V. (Germany) Revenue: by Geography 2023
  • Figure 32. Global Electrophoresis: by Type USD Million (2025-2030)
  • Figure 33. Global Electrophoresis: by Application USD Million (2025-2030)
  • Figure 34. Global Electrophoresis: by End Users USD Million (2025-2030)
  • Figure 35. South America Electrophoresis Share (%), by Country
  • Figure 36. Asia Pacific Electrophoresis Share (%), by Country
  • Figure 37. Europe Electrophoresis Share (%), by Country
  • Figure 38. MEA Electrophoresis Share (%), by Country
  • Figure 39. North America Electrophoresis Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories (United States)
  • GE Healthcare (United States)
  • Thermo Fisher Scientific Inc. (United States)
  • Danaher Corporation (United States)
  • Agilent Technologies (United States)
  • Merck Millipore (United States)
  • PerkinElmer, Inc. (United States)
  • QIAGEN N.V. (Germany)
Additional players considered in the study are as follows:
Harvard Bioscience, Inc. (United Sates) , C.B.S. Scientific Company, Inc. (United States) , Lonza Group Ltd. (Switzerland) , Shimadzu Corporation (Japan)
Select User Access Type

Key Highlights of Report


Jan 2024 158 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bio-Rad Laboratories (United States), GE Healthcare (United States), Thermo Fisher Scientific Inc. (United States), Danaher Corporation (United States), Agilent Technologies (United States), Merck Millipore (United States), PerkinElmer, Inc. (United States) and QIAGEN N.V. (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rising Adoption of Capillary Electrophoresis among the Chemical Industries" is seen as one of major influencing trends for Electrophoresis Market during projected period 2023-2030.
The Electrophoresis market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Electrophoresis Report?